Catheter Lock Solution to Prevent Infections in Newborns
Part of Genetic & congenital, Infections clinical trials.
This study tests a special locking solution placed in central venous catheters (thin tubes in babies' veins) to prevent infections. Researchers want to see if this approach keeps newborns safer during hospital care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby has a central venous catheter (a thin tube placed in a large vein) that has been in place for at least 2 days
- Your baby has not received antibiotics by injection or IV in the 48 hours before enrollment
- Your baby does not have an umbilical venous catheter (a catheter placed through the umbilical cord)
- Your baby does not have a suspected blood clotting disorder or family history of abnormal clotting
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new method to prevent infections from central lines (special IVs placed in large veins) in intensive care units. If you have a central line in place for more than 24 hours, this research may help improve your safety by finding better ways to avoid catheter-related bloodstream infections.
This study compares two types of central lines used in newborns in the intensive care unit—one placed in the belly button (UVC) and one in a vein in the arm or leg (PICC)—to see which has fewer complications and lasts longer. It may help doctors choose the safest option for your baby.
This study is looking at infections from central lines (special IVs in large veins) in ICU patients across China. It aims to understand how common these infections are and what factors contribute to them.
This study is testing a new blood test to see if it can help doctors decide when to use antibiotics for newborns who may have a late-onset infection. The goal is to reduce unnecessary antibiotic use.
This trial tests a new catheter lock solution (DefenCath) to prevent infections in people who need long-term IV nutrition through a central line. It compares the study drug to a standard heparin lock, and you'll be randomly assigned to one group.
This trial studies whether a medicine lock called taurolidine is safer or works better than a standard saline (salt water) lock for pediatric cancer patients with central venous lines. It’s meant to help prevent central-line infections.
Hear when a new CLABSI - Central Line Associated Bloodstream Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.